Navigation Links
Express Scripts Names Cathy R. Smith Chief Financial Officer
Date:1/14/2014

ST. LOUIS, Jan. 14, 2014 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) today announced that Cathy R. Smith will join the company as Executive Vice President and Chief Financial Officer, effective February 10, 2014.

(Logo:  http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO)

She will join Express Scripts from Walmart, where she has been executive vice president of strategy and chief financial officer for Walmart International since February 2010. Before joining Walmart, she was executive vice president and chief financial officer at GameStop. Prior to GameStop, she held executive vice president and chief financial officer roles at Centex Corp., a leading U.S. homebuilder, and Kennametal, a global industrial tool manufacturer. Earlier in her career, she served in various finance roles for 18 years in aerospace/defense companies.

"Cathy has demonstrated a solid track record of success at leading companies in diverse industries, and we believe her background is a great fit for Express Scripts," said George Paz, chairman and chief executive officer. "We look forward to welcoming Cathy and expect she will make important contributions to our continued growth."

About Express Scripts

Express Scripts manages more than a billion prescriptions each year for tens of millions of patients. On behalf of our clients – employers, health plans, unions and government health programs – we make the use of prescription drugs safer and more affordable. Express Scripts uniquely combines three capabilities – behavioral sciences, clinical specialization and actionable data – to create Health Decision Science, our innovative approach to help individuals make the best drug choices, pharmacy choices and health choices. Better decisions mean healthier outcomes.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services. 

For more information, visit Lab.Express-Scripts.com  or follow @ExpressScripts on Twitter.

Media Contact:
Brian Henry
314-684-6438
bhenry@express-scripts.com

Investor Contact:
David Myers
314-810-3115
investor.relations@express-scripts.com


'/>"/>
SOURCE Express Scripts Holding Company
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Lilly Oncology On Canvas: Expressions of a Cancer Journey Reaches Important Milestone With 2014 Competition
2. Express Scripts Announces Accelerated Share Repurchase Transaction
3. Lipitor Lawsuit News: As Lipitor Diabetes Lawsuits Move Forward, Bernstein Liebhard LLP Comments on JAMA Editorial Expressing Concern about the "Statinization" of U.S.
4. Financial Results, New Drug Applications, and Stock Price Movements - Research Report on Endo, Bristol-Myers Squibb, Express Scripts, AbbVie, and Incyte
5. Express Scripts to Present at the Credit Suisse Healthcare Conference
6. Express Scripts Launches Workers Compensation Program To Help Payers Reduce Narcotic Abuse
7. Express Scripts Reports Third Quarter 2013 Results
8. Ventana receives approval from Chinas FDA for first fully automated IHC companion diagnostic identifying ALK protein expression in lung cancer patients
9. Express Scripts Acquires SmartD Medicare Prescription Drug Plan; Adds to Industry-Leading Medicare Offering
10. Generex Provides Call-In Details for Conference Call with Members of the Antigen Express Scientific Advisory Board
11. Express Scripts To Discuss Outlook for Future Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... Elysium Health joins major pharmaceutical companies to ... Cambridge academic scientists through ... Institute today announces Elysium Health as a partner to the ... collaborative projects with academic researchers in Cambridge ... major research investment outside the U.S. for the ...
(Date:3/27/2017)... Summary This report provides all the information ... interests and activities since 2010. Description The Partnering Deals ... the partnering activity of one of the world,s leading life ... upon purchase to ensure inclusion of the most up to ... be delivered in PDF format within 1 working day of ...
(Date:3/27/2017)... , March 27, 2017  ImMAGE Biotherapeutics (OTCMKTS: ... immunotherapy successfully passed early toxicology and efficacy studies. The ... to target a specific protein, MAGE A, in an ... breast cancer. After 4 weeks of ... to show very little toxicity in a full toxicology ...
Breaking Medicine Technology:
(Date:3/28/2017)... DC (PRWEB) , ... March 28, 2017 , ... WHO: ... Dr. Toni Bark , WHAT: , Medical doctors and PhD scientists will speak to ... written to President Trump in support of an independent vaccine safety commission. , ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... instruments are critical to ensuring high-quality results and maintaining GMP and USP compliance. ... Laboratory Instruments in accordance with GMP requirements " these requirements are explained. ...
(Date:3/28/2017)... Vilnius, Lithuania (PRWEB) , ... March 28, 2017 ... ... identification technologies, today announced the release of two biometric time and attendance tracking ... Bio Attendance 4.0 software. NCheck Cloud Bio Attendance uses biometric face recognition ...
(Date:3/28/2017)... ... 2017 , ... In its ongoing effort to educate consumers ... and published an informational resource that addresses frequently asked questions. , “ ... site’s team of third party administrator (TPA) contributors regularly receives as employers, benefit ...
(Date:3/28/2017)... ... , ... A minimally invasive porcelain veneer is increasing in ... of Dental Laboratories (NADL) is informing dentists about the benefits of minimally invasive ... laboratories and technicians that create these veneers. , According to National Board ...
Breaking Medicine News(10 mins):